Neogen Chemicals Ltd (BOM:542665)

Q2 2026 Neogen Chemicals Ltd Earnings Call Transcript

Nov 10, 2025 / 11:30 AM GMT

Release Date Price: ₹1310.25 (-9.90%)

Transcript

Key Points

Positve

Neogen Chemicals Ltd (BOM:542665) achieved 8% revenue growth in Q2 FY26, driven by sustained demand and increased volume across its base and organolithium business.
The company reported a 16% improvement in gross profit, supported by a 350 basis points margin expansion.
Neogen Chemicals Ltd (BOM:542665) has made significant strides in corporate governance by separating the roles of Chairman and Managing Director, enhancing independent oversight.
The company is progressing towards commercializing its greenfield facility for battery chemicals, with mechanical completion expected by the end of the year.
Neogen Chemicals Ltd (BOM:542665) has formed a strategic joint venture with Morita Investments, marking the first Indo-Japan collaboration in the battery material space, which positions it as a key player in the lithium-ion supply chain.

Negative

The company's EBITDA was affected by elevated operating costs, including higher employee costs and increased insurance premiums following a fire incident.
There has been a delay in the demand for battery chemicals, particularly from overseas customers, impacting the company's revenue projections.
Neogen Chemicals Ltd (BOM:542665) faced challenges due to the temporary impact of a plant outage, which incurred additional costs related to contingency production arrangements.
The company had to execute a private placement of 200 crores in NCDs to maintain financial flexibility, indicating potential liquidity concerns.
The insurance payout for the fire incident has been delayed, affecting the company's cash flow and necessitating additional borrowing.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NEOE.NS - Neogen Chemicals Ltd
Q2 2026 Neogen Chemicals Ltd Earnings Call
Nov 10, 2025 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Neogen Chemicals Q2 F 526 earnings conference call.

As a reminder, all participant lines will be in the listen-only mode.

And there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing and 0 on the touchstone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Nishid Sulanki from CDR India.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.